C

Centessa Pharmaceuticals plc
D

CNTA

26.210
USD
-0.30
(-1.13%)
مغلق
حجم التداول
25,750
الربح لكل سهم
-2
العائد الربحي
-
P/E
-14
حجم السوق
3,874,360,339
المقالات

العنوان: Centessa Pharmaceuticals plc

القطاع: Healthcare
الصناعة: Biotechnology
Centessa Pharmaceuticals PLC is a clinical-stage pharmaceutical company. The company's pipeline assets include: SerpinPC for Hemophilia A, B; LB101 for Solid Tumors; ORX750 for Narcolepsy Type 1 (NT1) and other sleep disorders; MGX292 Pulmonary Arterial Hypertension (PAH); and Undisclosed for Solid Tumors.